The SGLT2 inhibitor empagliflozin improves the primary diabetic complications in ZDF rats-Reference-Cited by-同舟云学术

The SGLT2 inhibitor empagliflozin improves the primary diabetic complications in ZDF rats

Published:2017-10 Issue: Volume:13 Page:370-385
ISSN:2213-2317
Container-title:Redox Biology
language:en
Short-container-title:Redox Biology

Author:

Steven Sebastian,Oelze Matthias,Hanf Alina,Kröller-Schön Swenja,Kashani Fatemeh,Roohani Siyer,Welschof Philipp,Kopp Maximilian,Gödtel-Armbrust Ute,Xia Ning,Li Huige,Schulz Eberhard,Lackner Karl J.,Wojnowski Leszek,Bottari Serge P.,Wenzel Philip,Mayoux Eric,Münzel Thomas,Daiber Andreas

Publisher

Elsevier BV

Subject

Organic Chemistry,Biochemistry,Clinical Biochemistry

Reference84 articles.

1. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes;Nathan;N. Engl. J. Med.,2005

2. E.-R. O. investigators, empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes;Zinman;N. Engl. J. Med.,2015

3. Oxidative stress and diabetic cardiovascular complications;Jay;Free Radic. Biol. Med.,2006

4. Mechanisms underlying endothelial dysfunction in diabetes mellitus;Hink;Circ. Res.,2001

5. Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite;Zou;J. Clin. Investig.,2002

Cited by 220 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sodium–glucose cotransporter 2 inhibition through henagliflozin ameliorates cognitive impairment in patients with type 2 diabetes;Journal of Diabetes Investigation;2024-09-10

2. Advances in pathogenesis and treatment of vascular endothelial injury-related diseases mediated by mitochondrial abnormality;Frontiers in Pharmacology;2024-08-30

3. Empagliflozin-activated AMPK elicits neuroprotective properties in reserpine-induced depression via regulating dynamics of hippocampal autophagy/inflammation and PKCζ-mediated neurogenesis;Psychopharmacology;2024-08-19

4. Xelaglifam, a novel GPR40/FFAR1 agonist, exhibits enhanced β-arrestin recruitment and sustained glycemic control for type 2 diabetes;Biomedicine & Pharmacotherapy;2024-08

5. Empagliflozin mitigates methotrexate-induced nephrotoxicity in male albino rats: insights on the crosstalk of AMPK/Nrf2 signaling pathway;Future Journal of Pharmaceutical Sciences;2024-07-30